“Cost Saving and Predictive Factors of Response to Rituximab in Rheumatoid Arthritis, Including the IL-6 Promoter Gene Polymorphism”. Italian Journal of Public Health 9, no. 4 (October 1, 2012). Accessed July 27, 2026. https://test-ojs-unimi-it.archicoop.it/index.php/ijphjournal/article/view/22676.